Smoflipid 20% 6 % (Soybean Oil EMULSION) 6 %

SMOFLIPID 20% 6% is an intravenous emulsion containing soybean oil, designed to provide essential fatty acids and calories for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd.

Strength

6 %

Pack Size

100/250/500

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SMOFLIPID 20% 6% is used as a source of calories and essential fatty acids for patients who cannot consume nutrients orally. It is often administered intravenously to support nutritional needs in clinical settings. This emulsion is particularly useful for patients requiring parenteral nutrition, where oral intake is not feasible.

Side Effects

When administered intravenously, SMOFLIPID 20% 6% provides essential fatty acids that the body needs for various functions. It helps maintain energy levels and supports overall health. Some patients may experience mild side effects, but these are generally rare and temporary.

Precautions & Warnings

SMOFLIPID 20% 6% should be handled with care, ensuring proper storage and administration to avoid contamination. It is important to follow medical guidelines for intravenous administration. Patients with known allergies to soybean oil or any of the components should avoid using this product.

Avoid Interactions

SMOFLIPID 20% 6% may interact with other medications or supplements, particularly those that affect lipid metabolism. It is advisable to consult with a healthcare provider before combining this emulsion with other treatments. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

SMOFLIPID 20% 6% is used to provide essential fatty acids and calories for patients who cannot consume nutrients orally, often in clinical settings.

SMOFLIPID 20% 6% is administered intravenously, typically in a clinical setting under medical supervision.

Common side effects are generally rare and temporary, but may include mild reactions at the injection site.

SMOFLIPID 20% 6% may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Patients with known allergies to soybean oil or any of the components should avoid using SMOFLIPID 20% 6%.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.